An experimental treatment for an aggressive and lethal brain cancer has been published in Nature Medicine, paving the way for ...
Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer ...
The time of day of immunotherapy infusions does appear to affect patient outcomes. But convincing the wider oncology ...
From the approval of the first immune checkpoint inhibitors to the development of chimeric antigen receptor T cells, immunotherapy has demonstrated ...
Federal Health Minister Mark Butler passed on his best wishes on Monday. “Professor Scolyer is a fighter and I wish him all ...
The lab of Filippo Veglia, Ph.D., at The Wistar Institute has discovered a previously unknown mechanism for how aggressive ...
has raised $350.7 million to support a pipeline that includes a lead drug candidate now in a pivotal test that could support expanding melanoma treatment to a pair of new immunotherapy targets.
New findings could help make immunotherapies for brain cancer more effective. The team analyzed almost 200,000 individual immune cells in tumor samples taken from patients with glioma, the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results